Literature DB >> 10515423

Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma.

M de Perrot1, M Licker, M A Reymond, J Robert, A Spiliopoulos.   

Abstract

The proportion of elderly patients presenting with bronchogenic carcinoma is increasing. To study the impact of age on clinical presentation, management and outcome of patients, the authors have reviewed their clinical experience over the last 20 yrs. Between 1977 and 1996, 1,079 patients underwent thoracotomy for primary lung carcinoma in the authors' institution. Patients were grouped by age at the time of surgery as <60 yrs, 60-69 yrs and > or =70 yrs. Although the mode of clinical presentation was similar between all age groups, patients <60 yrs were more prone to have advanced stage carcinoma at the time of diagnosis. The rates of exploratory thoracotomy and pneumonectomy were higher in patients <70 yrs, whereas lobectomies and lesser resections largely predominated in patients > or =70 yrs. The mortality rate following lobectomy and lesser resection increased from 1.3% in patients <60 yrs to 5.5% in patients > or =60 yrs (p=0.04) and the mortality rate following pneumonectomy increased from 6.5% in patients <60 yrs to 13.7% in patients > or =70 yrs (p=0.24). The specific long-term survival, which included only the patients who died from primary lung carcinoma, was similar in all age groups. Operative mortality and survival rates are acceptable in patients > or =70 yrs. Therefore, age in itself should not constitute a contraindication to surgical lung resection for primary lung carcinoma as long as a careful preoperative assessment is performed to appropriately select surgical candidates.

Entities:  

Mesh:

Year:  1999        PMID: 10515423     DOI: 10.1034/j.1399-3003.1999.14b29.x

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

Review 1.  Lung cancer 7: management of lung cancer in elderly patients.

Authors:  R Booton; M Jones; N Thatcher
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

2.  Early and long-term results of pulmonary resection for non-small-cell lung cancer in patients over 75 years of age: a multi-institutional study.

Authors:  Andrea Dell'Amore; Marco Monteverde; Nicola Martucci; Stefano Sanna; Guido Caroli; Franco Stella; Davide Dell'Amore; Gaetano Rocco
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-11-23

Review 3.  SBRT in operable early stage lung cancer patients.

Authors:  Johannes Roesch; Nicolaus Andratschke; Matthias Guckenberger
Journal:  Transl Lung Cancer Res       Date:  2014-08

4.  Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer.

Authors:  M Guckenberger; N Andratschke; H Alheit; R Holy; C Moustakis; U Nestle; O Sauer
Journal:  Strahlenther Onkol       Date:  2013-09-21       Impact factor: 3.621

5.  SBRT for centrally localized NSCLC - What is too central?

Authors:  J Roesch; C Panje; F Sterzing; F Mantel; U Nestle; N Andratschke; M Guckenberger
Journal:  Radiat Oncol       Date:  2016-12-03       Impact factor: 3.481

6.  Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study.

Authors:  Shuri Aoki; Hideomi Yamashita; Akihiro Haga; Takeshi Ota; Wataru Takahashi; Sho Ozaki; Kanabu Nawa; Toshikazu Imae; Osamu Abe; Keiichi Nakagawa
Journal:  Oncol Lett       Date:  2018-07-23       Impact factor: 2.967

7.  PET/CT and brain MRI role in staging NSCLC: prospective assessment of the accuracy, reliability and cost-effectiveness.

Authors:  Vasiliki-Konstantina I Gkogkozotou; Ioannis C Gkiozos; Andriani G Charpidou; Elias A Kotteas; Paraskevi G Boura; Sophia N Tsagouli; Konstantinos N Syrigos
Journal:  Lung Cancer Manag       Date:  2018-05-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.